ATP-sensitive potassium (KATP) channels couple cell metabolism to electrical activity of the plasma membrane by regulating membrane K+ fluxes. A reduction in metabolism opens KATP channels, producing K+ efflux, membrane hyperpolarization, and suppression of electrical activity. Conversely, increased metabolism closes KATP channels. The consequent membrane depolarization stimulates electrical activity and may thereby trigger cellular responses such as the release of hormones and neurotransmitters, or muscle contraction. Given their critical role in regulating electrical excitability in many cells, it is evident that disruption of KATP channel function can lead to disease. To date, mutations in KATP channel genes have been shown to cause neonatal diabetes, hyperinsulinemia, and dilated cardiomyopathy in humans. The KATP channel is an octameric complex of 4 Kir6.x and 4 SURx subunits. The pore-forming Kir6.x subunit belongs to the inwardly rectifying family of potassium channels[1].

[1] ATP-sensitive potassium channelopathies: focus on insulin secretion. F.M. Ashcroft. J. Clin. Invest. 2005, 115, 2047-2058.

7 Item(s)

per page
Axon ID Name Description From price
2064 Glibenclamide potassium salt KATP channel blocker; inhibits SUR1 €50.00
3503 Glipizide KATP channel blocker; inhibits SUR1 €50.00
1757 HMR 1098 K+ channel blocker (SUR1/Kir6.2 selective) €95.00
3641 Nateglinide KATP channel blocker; inhibits SUR1 €60.00
1647 NN 414 K+ channel opener (SUR1/Kir6.2 selective) €110.00
1274 PNU 37883 hydrochloride K+ channel blocker (ATP sensitive, vascular) €85.00
3365 Repaglinide K+ channel blocker (SUR1/Kir6.2 selective) €90.00

7 Item(s)

per page
Please wait...